0

Hypertension Collection
 101-120 of 658 Articles
Quality Indicators for Assessing Care of Vulnerable Elders |  16 October 2001
Quality Indicators for Appropriate Medication Use in Vulnerable Elders
Eric L. Knight, MD, MPH; Jerry Avorn, MD
Ann Intern Med. 2001;135(8_Part_2):703-710. doi:10.7326/0003-4819-135-8_Part_2-200110161-00009
Quality Indicators for Assessing Care of Vulnerable Elders |  16 October 2001 FREE
ACOVE Quality Indicators
Ann Intern Med. 2001;135(8_Part_2):653-667. doi:10.7326/0003-4819-135-8_Part_2-200110161-00004
Articles |  18 September 2001
Diagnostic Tests for Renal Artery Stenosis in Patients Suspected of Having Renovascular Hypertension: A Meta-Analysis
G. Boudewijn C. Vasbinder, MD; Patricia J. Nelemans, MD, PhD; Alfons G.H. Kessels, MD, MSc; et al.
Ann Intern Med. 2001;135(6):401-411. doi:10.7326/0003-4819-135-6-200109180-00009
Academia and the Profession |  4 September 2001
Perceptions about Complementary Therapies Relative to Conventional Therapies among Adults Who Use Both: Results from a National Survey
David M. Eisenberg, MD; Ronald C. Kessler, PhD; Maria I. Van Rompay, BA; et al.
Ann Intern Med. 2001;135(5):344-351. doi:10.7326/0003-4819-135-5-200109040-00011
Brief Communications |  21 August 2001
Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
Anna M. Sawka, MD; William F. Young, MD; Geoffrey B. Thompson, MD; et al.
Ann Intern Med. 2001;135(4):258-261. doi:10.7326/0003-4819-135-4-200108210-00010
Articles |  21 August 2001
Hormone Replacement Therapy and Longitudinal Changes in Blood Pressure in Postmenopausal Women
Angelo Scuteri, MD, PhD; Angelo J.G. Bos, MD, PhD; Larry J. Brant, PhD; et al.
Ann Intern Med. 2001;135(4):229-238. doi:10.7326/0003-4819-135-4-200108210-00007
Editorials |  17 July 2001
The Effect of Angiotensin-Converting Enzyme Inhibitors on the Progression of Nondiabetic Renal Disease: A Pooled Analysis of Individual-Patient Data from 11 Randomized, Controlled Trials
Robert W. Schrier, MD; Raymond O. Estacio, MD
Ann Intern Med. 2001;135(2):138-139. doi:10.7326/0003-4819-135-2-200107170-00015
Articles |  17 July 2001
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease: A Meta-Analysis of Patient-Level Data
Tazeen H. Jafar, MD, MPH; Christopher H. Schmid, PhD; Marcia Landa, MA; et al.
Ann Intern Med. 2001;135(2):73-87. doi:10.7326/0003-4819-135-2-200107170-00007
Articles |  5 June 2001
Home Monitoring Service Improves Mean Arterial Pressure in Patients with Essential Hypertension: A Randomized, Controlled Trial
Mary A.M. Rogers, PhD, MS; David Small, MD; Debra A. Buchan, MD; et al.
Ann Intern Med. 2001;134(11):1024-1032. doi:10.7326/0003-4819-134-11-200106050-00008
Articles |  17 April 2001
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial
Johannes F.E. Mann, MD; Hertzel C. Gerstein, MD; Janice Pogue, MSc; et al.
Ann Intern Med. 2001;134(8):629-636. doi:10.7326/0003-4819-134-8-200104170-00007
Articles |  6 March 2001
Should All Patients with Type 1 Diabetes Mellitus and Microalbuminuria Receive Angiotensin-Converting Enzyme Inhibitors?: A Meta-Analysis of Individual Patient Data
The ACE Inhibitors in Diabetic Nephropathy Trialist Group*
Ann Intern Med. 2001;134(5):370-379. doi:10.7326/0003-4819-134-5-200103060-00009
Editorials |  2 January 2001
Obesity and Hypertension: What Should We Do?
Thomas G. Pickering, MD, DPhil
Ann Intern Med. 2001;134(1):72-74. doi:10.7326/0003-4819-134-1-200101020-00016
Articles |  2 January 2001
Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II
Victor J. Stevens, PhD; Eva Obarzanek, PhD; Nancy R. Cook, ScD; et al.
Ann Intern Med. 2001;134(1):1-11. doi:10.7326/0003-4819-134-1-200101020-00007
Brief Communications |  17 October 2000
Long-Term Outcomes of Scleroderma Renal Crisis
Virginia D. Steen, MD; Thomas A. Medsger, MD
Ann Intern Med. 2000;133(8):600-603. doi:10.7326/0003-4819-133-8-200010170-00010
Editorials |  21 March 2000
Epoprostenol (Prostacyclin) and Pulmonary Hypertension
Alfred P. Fishman, MD
Ann Intern Med. 2000;132(6):500-502. doi:10.7326/0003-4819-132-6-200003210-00013
Articles |  21 March 2000
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease: A Randomized, Controlled Trial
David B. Badesch, MD; Victor F. Tapson, MD; Michael D. McGoon, MD; et al.
Ann Intern Med. 2000;132(6):425-434. doi:10.7326/0003-4819-132-6-200003210-00002
Ideas and Opinions |  1 February 2000
The Diastolic Blood Pressure in Systolic Hypertension
Harold Smulyan, MD; Michel E. Safar, MD
Ann Intern Med. 2000;132(3):233-237. doi:10.7326/0003-4819-132-3-200002010-00010
Currents |  16 November 1999
Computational Genomics: The Medicine of the Future?
Gail Dutton
Ann Intern Med. 1999;131(10):801-804. doi:10.7326/0003-4819-131-10-199911160-00101
Articles |  2 November 1999 FREE
The Cost-Effectiveness of Treating All Patients with Type 2 Diabetes with Angiotensin-Converting Enzyme Inhibitors
Lubor Golan, MD, MS; John D. Birkmeyer, MD; H. Gilbert Welch, MD, MPH
Ann Intern Med. 1999;131(9):660-667. doi:10.7326/0003-4819-131-9-199911020-00005
Editorials |  19 October 1999
Integrating Routine Inquiry about Domestic Violence into Daily Practice
Carole Warshaw, MD; Elaine Alpert, MD
Ann Intern Med. 1999;131(8):619-620. doi:10.7326/0003-4819-131-8-199910190-00012
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)